Cargando…

1302. Impact of Insurance Coverage on the Route of Antibiotic Treatment for Forefoot Osteomyelitis

BACKGROUND: Recent studies suggest oral antibiotics can be a non-inferior alternative to intravenous antibiotics for treating bone and joint infections. In this study, we aimed to investigate whether insurance type affects the choice of antibiotic treatment routes and whether the route of antibiotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritter, Austin, Ovalle, Anais, Hadeel, Zainah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677514/
http://dx.doi.org/10.1093/ofid/ofad500.1141
_version_ 1785150147943989248
author Ritter, Austin
Ovalle, Anais
Hadeel, Zainah
author_facet Ritter, Austin
Ovalle, Anais
Hadeel, Zainah
author_sort Ritter, Austin
collection PubMed
description BACKGROUND: Recent studies suggest oral antibiotics can be a non-inferior alternative to intravenous antibiotics for treating bone and joint infections. In this study, we aimed to investigate whether insurance type affects the choice of antibiotic treatment routes and whether the route of antibiotic treatment influences the delivery of home health services. METHODS: We conducted a retrospective chart review of non-bacteremic patients who underwent amputations for forefoot osteomyelitis with residual signs of infection on proximal bone cultures and were discharged home from the hospital. Of 461 patients scheduled for hospital follow-up visits for bone and joint infections in our community practice infectious diseases clinic from January 2019 to December 2022, 40 met the inclusion criteria. Results were analyzed with multivariable logistic regression, selecting models with the lowest Akaike Information Criterion. [Figure: see text] RESULTS: The placement of PICC lines decreased significantly over time (OR 0.34, 95% CI: 0.14 - 0.71, p = 0.01), mirroring national trends favoring increased oral antibiotic use. After controlling for the year of treatment, we observed a trend towards patients with Medicaid insurance more frequently receiving IV antibiotics (OR 4.8, 95% CI: 1.0 - 29, p = 0.06). We found no evidence that the antibiotic administration route led to differences in the delivery of home health services at the time of discharge (p = 0.99). PICC Placement Percentage by Year and Insurance [Figure: see text] Percentage of PICC line Placement by year in patients with and without Medicaid Insurance during hospital encounter PICC Placement Frequency by Insurance and Home Nursing [Figure: see text] Frequency of PICC placement in patients during hospital encounters based on (A) if a patient has Medicaid insurance and (B) if home nursing is ordered at discharge Organisms Cultured by Year [Figure: see text] Frequency of organisms cultured on proximal bone cultures by year of study CONCLUSION: Our findings suggest a trend towards patients with Medicaid insurance more frequently receiving IV antibiotics, despite the higher direct and indirect costs. It remains unclear whether this trend is due to differences in the severity of infections or microbiological resistance patterns. Future studies should assess the interaction of psychosocial and microbiological factors in influencing shared decisions regarding the route of antibiotic treatment outside of clinical trial settings. Organisms Cultured by Antibiotic Route, Insurance Type, and Home Nursing Orders [Figure: see text] Frequency of PICC line placement (A), Insurance coverage (B), and ordered for home nursing at discharge (C) by organisms cultured from proximal bone margins DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10677514
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106775142023-11-27 1302. Impact of Insurance Coverage on the Route of Antibiotic Treatment for Forefoot Osteomyelitis Ritter, Austin Ovalle, Anais Hadeel, Zainah Open Forum Infect Dis Abstract BACKGROUND: Recent studies suggest oral antibiotics can be a non-inferior alternative to intravenous antibiotics for treating bone and joint infections. In this study, we aimed to investigate whether insurance type affects the choice of antibiotic treatment routes and whether the route of antibiotic treatment influences the delivery of home health services. METHODS: We conducted a retrospective chart review of non-bacteremic patients who underwent amputations for forefoot osteomyelitis with residual signs of infection on proximal bone cultures and were discharged home from the hospital. Of 461 patients scheduled for hospital follow-up visits for bone and joint infections in our community practice infectious diseases clinic from January 2019 to December 2022, 40 met the inclusion criteria. Results were analyzed with multivariable logistic regression, selecting models with the lowest Akaike Information Criterion. [Figure: see text] RESULTS: The placement of PICC lines decreased significantly over time (OR 0.34, 95% CI: 0.14 - 0.71, p = 0.01), mirroring national trends favoring increased oral antibiotic use. After controlling for the year of treatment, we observed a trend towards patients with Medicaid insurance more frequently receiving IV antibiotics (OR 4.8, 95% CI: 1.0 - 29, p = 0.06). We found no evidence that the antibiotic administration route led to differences in the delivery of home health services at the time of discharge (p = 0.99). PICC Placement Percentage by Year and Insurance [Figure: see text] Percentage of PICC line Placement by year in patients with and without Medicaid Insurance during hospital encounter PICC Placement Frequency by Insurance and Home Nursing [Figure: see text] Frequency of PICC placement in patients during hospital encounters based on (A) if a patient has Medicaid insurance and (B) if home nursing is ordered at discharge Organisms Cultured by Year [Figure: see text] Frequency of organisms cultured on proximal bone cultures by year of study CONCLUSION: Our findings suggest a trend towards patients with Medicaid insurance more frequently receiving IV antibiotics, despite the higher direct and indirect costs. It remains unclear whether this trend is due to differences in the severity of infections or microbiological resistance patterns. Future studies should assess the interaction of psychosocial and microbiological factors in influencing shared decisions regarding the route of antibiotic treatment outside of clinical trial settings. Organisms Cultured by Antibiotic Route, Insurance Type, and Home Nursing Orders [Figure: see text] Frequency of PICC line placement (A), Insurance coverage (B), and ordered for home nursing at discharge (C) by organisms cultured from proximal bone margins DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677514/ http://dx.doi.org/10.1093/ofid/ofad500.1141 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Ritter, Austin
Ovalle, Anais
Hadeel, Zainah
1302. Impact of Insurance Coverage on the Route of Antibiotic Treatment for Forefoot Osteomyelitis
title 1302. Impact of Insurance Coverage on the Route of Antibiotic Treatment for Forefoot Osteomyelitis
title_full 1302. Impact of Insurance Coverage on the Route of Antibiotic Treatment for Forefoot Osteomyelitis
title_fullStr 1302. Impact of Insurance Coverage on the Route of Antibiotic Treatment for Forefoot Osteomyelitis
title_full_unstemmed 1302. Impact of Insurance Coverage on the Route of Antibiotic Treatment for Forefoot Osteomyelitis
title_short 1302. Impact of Insurance Coverage on the Route of Antibiotic Treatment for Forefoot Osteomyelitis
title_sort 1302. impact of insurance coverage on the route of antibiotic treatment for forefoot osteomyelitis
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677514/
http://dx.doi.org/10.1093/ofid/ofad500.1141
work_keys_str_mv AT ritteraustin 1302impactofinsurancecoverageontherouteofantibiotictreatmentforforefootosteomyelitis
AT ovalleanais 1302impactofinsurancecoverageontherouteofantibiotictreatmentforforefootosteomyelitis
AT hadeelzainah 1302impactofinsurancecoverageontherouteofantibiotictreatmentforforefootosteomyelitis